Suzhou Suncadia Biopharmaceuticals Co., Ltd.

This early-stage study aims to test the safety and initial effectiveness of a new drug called SHR-4298 in patients with advanced solid tumors that have returned or spread. The trial will involve about 200 participants to find the right dose and see how well the body handles the t…

This study is testing the safety and effectiveness of a new drug called SHR-4375 when given alongside other cancer therapies. It is for adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find the right dose and see if the drug …

This study is for people with a high-risk form of bladder cancer that has returned after standard BCG immunotherapy. It will compare a new combination treatment (SHR-1501 plus BCG) against standard chemotherapy drugs chosen by the doctor. The goal is to see if the new combination…

This study is testing an experimental drug called SHR-1826 for people with advanced non-small cell lung cancer that has spread or can't be removed by surgery. About 90 participants who have already tried other treatments will receive the drug through an IV every three weeks. Rese…

This study is testing whether adding two new immunotherapy drugs (adebrelimab and SHR-8068) to standard chemotherapy and radiation before surgery helps people with locally advanced rectal cancer. Researchers want to see if this combination helps shrink tumors more effectively and…

This study is for women whose cervical cancer has returned or spread after standard chemotherapy and immunotherapy. It will compare a new drug called SHR-A2102 against standard chemotherapy to see which helps patients live longer. The main goal is to see if the new drug improves …